Fundz

Ironwood Pharmaceuticals Inc reported raising $150 Million in an initial SEC Form D filing, from an offering of $150 Million

PUBLIC · IRWDOct 11, 2016

Amount Raised

$150 Million

$150 Million sold, per SEC Form D (first sale Oct 11, 2016)

Round Type

Venture

BostonBiotechnologyHealth CareMedical

Quick answer

Ironwood Pharmaceuticals raised $150 Million in a funding round, dated October 11, 2016. Ironwood Pharmaceuticals is based in Boston, Massachusetts, United States.

How much did Ironwood Pharmaceuticals raise?
Ironwood Pharmaceuticals raised $150 Million in a funding round on October 11, 2016.
What does Ironwood Pharmaceuticals do?
Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI..
Where is Ironwood Pharmaceuticals based and how big is it?
Ironwood Pharmaceuticals is based in Boston, Massachusetts, United States. Fundz records about 261 employees.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Ironwood Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Cleveland Diagnostics raised $440K on November 23, 2016.
  • ShockWave Medical raised $45M on November 22, 2016.
  • Decoy Therapeutics Inc. raised $132K (Pre-Seed) on November 21, 2016.
  • Monteris Medical raised $6.8M on November 21, 2016.
  • pulseData, Inc. raised $3.2M (Seed) on October 31, 2016.
  • Streamex Corp. raised $520K on October 31, 2016.

Who to call at Ironwood Pharmaceuticals, and when

A new round usually means Ironwood Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ironwood Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ironwood Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ironwood Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ironwood Pharmaceuticals

Location

100 Summer Street, Suite 2300

Boston, Massachusetts, United States

About

Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). In June 2023, the U.S. Food and Drug Administration also approved LINZESS for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Under the guidance of our seasoned industry leaders, we continue to build upon our history of GI innovation and challenge what has been done before to shape what the future holds. We keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts. We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ironwood Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ironwood Pharmaceuticals's next move

See what Strategic adds

Ironwood Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.